Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy Academic Article uri icon

Overview

MeSH Major

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

abstract

  • Data suggest that treatment with 2 courses of IGIV-C administered 3 weeks apart may be required for initial improvement, and continued maintenance therapy may be necessary to achieve a maximal therapeutic response. Trial Registration clinicaltrials.gov Identifier: NCT00220740.

publication date

  • July 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/archneurol.2010.105

PubMed ID

  • 20457948

Additional Document Info

start page

  • 802

end page

  • 7

volume

  • 67

number

  • 7